GlaxoSmithKline PLC (GSK) — Capital Reinvestment Ratio
GlaxoSmithKline PLC (GSK) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (GBX2.22 Billion) in capital expenditures (GBX879.00 Million). See net asset quality index of GlaxoSmithKline PLC to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GlaxoSmithKline PLC Capital Reinvestment Ratio (1990–2024)
This chart tracks GlaxoSmithKline PLC's Capital Reinvestment Ratio across 40 annual periods. Check GlaxoSmithKline PLC total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for GlaxoSmithKline PLC (1990–2024)
Year-by-year Capital Reinvestment Ratio for GlaxoSmithKline PLC from 1990 to 2024. For live market cap and broader valuation context, see GSK company net worth.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.45x | GBX6.55 Billion | GBX2.98 Billion | ▲ +31.4% |
| 2023 | 0.35x | GBX6.77 Billion | GBX2.34 Billion | ▲ +13.5% |
| 2022 | 0.31x | GBX7.40 Billion | GBX2.26 Billion | ▼ -17.2% |
| 2021 | 0.37x | GBX7.95 Billion | GBX2.93 Billion | ▲ +39.0% |
| 2020 | 0.27x | GBX8.44 Billion | GBX2.24 Billion | ▼ -1.6% |
| 2019 | 0.27x | GBX8.02 Billion | GBX2.16 Billion | ▲ +26.5% |
| 2018 | 0.21x | GBX8.42 Billion | GBX1.80 Billion | ▼ -33.0% |
| 2017 | 0.32x | GBX6.92 Billion | GBX2.20 Billion | ▼ -12.1% |
| 2016 | 0.36x | GBX6.50 Billion | GBX2.35 Billion | ▼ -51.1% |
| 2015 | 0.74x | GBX2.57 Billion | GBX1.90 Billion | ▲ +118.7% |
| 2014 | 0.34x | GBX5.18 Billion | GBX1.75 Billion | ▲ +43.6% |
| 2013 | 0.24x | GBX7.22 Billion | GBX1.70 Billion | ▼ -32.2% |
| 2012 | 0.35x | GBX4.38 Billion | GBX1.52 Billion | ▲ +63.5% |
| 2011 | 0.21x | GBX6.25 Billion | GBX1.33 Billion | ▼ -11.7% |
| 2010 | 0.24x | GBX6.80 Billion | GBX1.64 Billion | ▲ +0.7% |
| 2009 | 0.24x | GBX7.84 Billion | GBX1.87 Billion | ▼ -15.6% |
| 2008 | 0.28x | GBX7.31 Billion | GBX2.07 Billion | ▼ -23.5% |
| 2007 | 0.37x | GBX5.79 Billion | GBX2.14 Billion | ▼ -7.9% |
| 2006 | 0.40x | GBX3.96 Billion | GBX1.59 Billion | ▲ +90.0% |
| 2005 | 0.21x | GBX5.59 Billion | GBX1.18 Billion | ▲ +295.2% |
| 2004 | 0.05x | GBX4.77 Billion | GBX255.00 Million | ▼ -75.6% |
| 2003 | 0.22x | GBX4.85 Billion | GBX1.06 Billion | ▼ -45.4% |
| 2002 | 0.40x | GBX3.06 Billion | GBX1.23 Billion | ▲ +65.4% |
| 2001 | 0.24x | GBX4.61 Billion | GBX1.12 Billion | ▼ -59.3% |
| 2000 | 0.60x | GBX1.85 Billion | GBX1.10 Billion | ▼ -49.1% |
| 1999 | 1.17x | GBX510.00 Million | GBX597.00 Million | ▲ +1.0% |
| 1998 | 1.16x | GBX410.00 Million | GBX475.00 Million | ▲ +71.7% |
| 1997 | 0.67x | GBX615.00 Million | GBX415.00 Million | ▲ +42.9% |
| 1996 | 0.47x | GBX849.00 Million | GBX401.00 Million | ▼ -13.5% |
| 1995 | 0.55x | GBX1.25 Billion | GBX684.00 Million | ▲ +175.5% |
| 1995 | 0.20x | GBX2.45 Billion | GBX485.59 Million | ▲ +0.0% |
| 1994 | 0.20x | GBX2.45 Billion | GBX485.59 Million | ▼ -63.7% |
| 1994 | 0.55x | GBX1.05 Billion | GBX575.00 Million | ▲ +0.0% |
| 1993 | 0.55x | GBX1.05 Billion | GBX575.00 Million | ▼ -16.7% |
| 1993 | 0.66x | GBX927.00 Million | GBX608.00 Million | ▲ +0.0% |
| 1992 | 0.66x | GBX927.00 Million | GBX608.00 Million | ▼ -27.5% |
| 1992 | 0.90x | GBX657.00 Million | GBX594.00 Million | ▲ +0.0% |
| 1991 | 0.90x | GBX657.00 Million | GBX594.00 Million | ▼ -8.2% |
| 1991 | 0.99x | GBX615.00 Million | GBX606.00 Million | ▲ +0.0% |
| 1990 | 0.99x | GBX615.00 Million | GBX606.00 Million | — |